Genpact to Release Third Quarter Results in 2026
PR Newswire
1h ago
Ai Focus
Genpact indicates that the third-quarter financial report will be released after the close of U.S. stocks on November 5, 2026, and a conference call to discuss the results will be held at 5:00 p.m. (Eastern Time) on the same day.
Helpful
No.Help

New York, October 8, 2026 / PRNewswire / -- Genpact (NYSE ticker: G), this " Agentic Operations " company, will announce its financial results for the third quarter of 2026 after the close of U.S. trading on Thursday, November 5, 2026.

After the performance report is released, the management team of Genpact will hold a teleconference at 5:00 PM Eastern Time to discuss the company's performance. Participants are advised to register in advance to obtain the dial-in number and a unique PIN code for easy connection. Although it is recommended to log in as early as possible, registration and connection will remain open throughout the teleconference.

Live webcast will be provided through the Genpact Investor Relations website at that time. Shortly after the meeting, a replay and written record will be published on that website.

About Genpact

Genpact (New York Stock Exchange ticker: G) is a “Agentic Operations” company where AI is combined with context-rich process intelligence. The company operates and transforms critical tasks for enterprises around the world. Genpact's Agentic Operations is built on decades of experience in managing core business processes on a large scale, covering areas such as finance, supply chain, banking, and insurance. The company's flywheel, composed of advanced technology, a trusted data foundation, and deep ecosystem partnerships, enables businesses to rapidly move from experimentation to scale. AI agents bring speed and precision, while human experts provide judgment; together, they deliver results that customers can measure.

For more information, please visit genpact.com, as well as LinkedIn, X, YouTube, and Facebook.

Contact Information:

Tip
$0
Like
0
Save
0
Views 14
CoinMeta reminds readers to view blockchain rationally, stay aware of risks, and beware of virtual token issuance and speculation. All content on this site represents market information or related viewpoints only and does not constitute any form of investment advice. If you find sensitive content, please click“Report”,and we will handle it promptly。
Submit
Comment 0
Hot
Latest
No comments yet. Be the first!
Related
Grain Management sells 800 MHz spectra to SpaceX for use in Starlink Mobile
SpaceX has agreed to acquire Grain Management's 800 MHz spectrum combinations across the United States for use in Starlink Mobile's satellite connectivity services. This transaction still requires approval from the Federal Communications Commission of the United States and must meet other delivery conditions.
The Cryptonomist
·2026-10-09 06:34:04
8
Bitcoin Lightning Network Integration Enhances WhiteBIT Functionality
WhiteBIT has now supported Bitcoin Lightning Network, providing its 10 million users with new methods for Bitcoin top-ups, withdrawals, and transactions. This integration utilizes the infrastructure of Voltage and also extends to QR code payment and sending/receiving functions.
The Cryptonomist
·2026-10-09 06:34:00
8
Pfizer's stock price reports $27.75, down 0.89%
As of 10:06 a.m. Eastern Time on Thursday, Pfizer's stock price was at $27.75, down 0.89% from the previous close. The article states that its daily chart trend is neutral, with mixed short-term signals. The key support level is at $27.64, and the pivot point is at $27.91.
The Cryptonomist
·2026-10-09 06:23:04
11
Option traders are moderately bearish on Bank of America, with the stock price falling by 1.01%
According to TheFly, option traders at Bank of America (BAC) are generally mildly bearish. Although the number of call options traded is still higher than that of put options, the put/call skew has deepened, indicating an increasing demand for downside protection. The stock price fell by 55 cents to around $53.55, and the company will release its financial report before the opening on October 14, 2026.
Businessinsider
·2026-10-09 06:23:03
11
Pacira BioSciences rises by 44.03%
Pacira BioSciences ( PCRX ) rose 44.03% during trading on Thursday. The article stated that its daily, hourly, and 15-minute technical indicators were all in overbought zones, but the overall trend remained bullish. Previously, there were also media reports indicating that the company had reached a European distribution partnership with Molteni Farmaceutici.
The Cryptonomist
·2026-10-09 06:11:29
14
View More